dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Walma, M. S. |
dc.contributor.author | Rombouts, S. J. |
dc.contributor.author | Brada, L. J. H. |
dc.contributor.author | Borel Rinkes, I. H. |
dc.contributor.author | Bosscha, K. |
dc.contributor.author | Bruijnen, R. C. |
dc.contributor.author | Pando Rau, Elizabeth |
dc.date.accessioned | 2021-12-28T10:23:02Z |
dc.date.available | 2021-12-28T10:23:02Z |
dc.date.issued | 2021-04-29 |
dc.identifier.citation | Walma MS, Rombouts SJ, Brada LJH, Borel Rinkes IH, Bosscha K, Bruijnen RC, et al. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial. Trials. 2021 Apr 29;22:313. |
dc.identifier.issn | 1745-6215 |
dc.identifier.uri | https://hdl.handle.net/11351/6750 |
dc.description | Quimioteràpia; Càncer de pàncrees localment avançat; Ablació per radiofreqüència |
dc.description.sponsorship | Olympus Netherlands BV supported the investigator-initiated PELICAN trial with material support by providing the RFA generators and electrodes for the study. They did not have and will not have any influence on the trial design, data collection, interpretation of the data, manuscript development, or decision to publish. Furthermore, the study protocol has undergone full external peer review and received a data management and monitoring grant from the Dutch Cancer Society (grant number 2014-7244). |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Trials;22 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pàncrees - Càncer - Tractament |
dc.subject | Extirpació (Cirurgia) |
dc.subject | Quimioteràpia |
dc.subject.mesh | Radiofrequency Ablation |
dc.subject.mesh | Pancreatic Neoplasms |
dc.subject.mesh | /therapy |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.title | Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s13063-021-05248-y |
dc.subject.decs | ablación por radiofrecuencia |
dc.subject.decs | neoplasias pancreáticas |
dc.subject.decs | /terapia |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Walma MS, Rombouts SJ, Brada LJH] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Departments of Surgery, Radiology and Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Borel Rinkes IH, Bruijnen RC] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. [Bosscha K] Departments of Surgery and Medical Oncology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands. [Pando E] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 33926539 |
dc.identifier.wos | 000654876700002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |